Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Sickle cell disease (SCD) induces a chronic prothrombotic state. Central venous access devices (CVADs) are commonly used for chronic transfusions and iron chelation in this population. CVADs are an additional venous thromboembolism (VTE) risk factor. The role of thromboprophylaxis in this setting is...

Full description

Bibliographic Details
Main Authors: Stéphanie Forté, Gonzalo De Luna, Jameel Abdulrehman, Nafanta Fadiga, Olivia Pestrin, Anne-Laure Pham Hung d’Alexandry d’Orengiani, John Chinawaeze Aneke, Henri Guillet, Dalton Budhram, Anoosha Habibi, Richard Ward, Pablo Bartolucci, Kevin H. M. Kuo
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
anemia
sickle cell
central venous catheters
upper extremity deep vein thrombosis
vascular access devices
venous thromboembolism
Online Access:https://www.mdpi.com/2077-0383/11/5/1193

Similar Items

Similar Items